Low uptake may reflect barriers—misinformation, access or shifting insurance coverage—not simply waning need.

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most ...

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

Presented by The Coalition to Strengthen America’s Healthcare — The Trump administration on Tuesday said it plans to limit ...

U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...

Top officials for the Food and Drug Administration laid out new requirements for yearly updates to COVID shots, saying they’d ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could ...